
- Telehealth visits

Matt Zinter, MD
He | Him | HisPediatric Critical Care • PediatricsProgram Director, Pediatric Immunocompromised Critical Care- Telehealth visits



Matt Zinter, MD
He | Him | HisPediatric Critical Care • PediatricsProgram Director, Pediatric Immunocompromised Critical Care- Telehealth visits
On this page
About me
Dr. Matt Zinter is a pediatric critical care specialist who treats children when they have life-threatening illness or injury. He specializes in caring for children with cancer or immune disorders as well as those who have had stem cell transplants or other cellular therapies. Seeking to bring healing and hope to critically ill children, he combines compassionate bedside care with cutting-edge science and opportunities to join clinical trials (studies of promising new treatments). He is program director for pediatric immunocompromised critical care at UCSF Benioff Children's Hospitals.
Zinter's research program focuses on understanding why children may develop difficulty breathing after an infection or injury to the lung. Partnering with patients and their families, his laboratory studies the lung microbiome (which comprises the bacteria, viruses and fungi living inside the lung) and measures inflammation and tissue stress in the lungs. His aim is to develop new diagnostic tests and treatments for children with lung diseases and other serious health problems.
Zinter earned his medical degree at Washington University in St. Louis. He completed a residency in pediatrics and a fellowship in pediatric critical care medicine at UCSF.
Education & training
Board certification
- Pediatric Critical Care Medicine, American Board of Pediatrics
Fellowship
- Pediatric Critical Care, UCSF School of Medicine -GME
Residency
- Pediatrics, UCSF School of Medicine -GME
Internship
- Pediatrics, UCSF School of Medicine -GME
Degree
- MD, Washington University School of Medicine in St. Louis
Academic Title
- Professor-in-Residence
My expertise
Specialties
- Pediatric Critical Care
- Pediatrics
My research
Clinical trials
Stress Hydrocortisone In Pediatric Septic ShockOpens in a new window
Recruiting
Appearance of new or progression of existing organ dysfunctions according to PELOD-2 definitions. PELOD-2 considers 5 organ dysfunctions (neurological, cardiov...TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT PatientsOpens in a new window
Recruiting
Participants will be assessed for lung injury at 24 months after HSCTAzithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in ChildrenOpens in a new window
Recruiting
Duration of hospitalization in days for enrolled subjectsTargeted Reversal of Inflammation in Pediatric Sepsis-induced MODSOpens in a new window
Recruiting
The cumulative Pediatric Logistic Organ Dysfunction (PELOD)-2 score over 28 days from randomization. The range of daily PELOD-2 scores is from 0 - 33, with hig...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
